Published in Hospital Law Weekly, November 30th, 2006
This trend article about Oregon Health & Science University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
"Tumor resistance to alkylating agents such as BCNU has been found to be associated with intracellular expression of O-6-methylguanine-DNA methyltransferase (MGMT). Administration of O-6-BG, a substrate that inactivates MGMT, may help overcome...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.